Take a look at IMU. Drugs in phase 1 and 2 trials. ANP could be 1 trial away from approval.
Fair value share price after last trial and competitor problems should be over 200million now (check out IHL for example).
A MC of 500 million when trial starts aint too far away from where it should be. ODDs in EU and US, voucher etc.
There is no interest in ANP at the moment. Lets see if the announcements on the way light that fire. One trial away from approval! Thats huge. Just have to meet same endpoints as already achieved in last trial. Thats huge.
Noone wanting to sell as they think the price is too low. Noone wants to buy, as price doubled in past 5 months and they still want news. This means no liquidity. Hence floundering share price.
We need strong announcements to give the direction and time frames for the future. Have a look at that IMU chart again to see what that can result in.
Where others have failed will Atl1102 succeed ?, page-68
-
- There are more pages in this discussion • 1,029 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
